Christopher D. Roberts
Amministratore Delegato presso Civetta Therapeutics LLC
Profilo
Christopher D.
Roberts is currently the Chief Executive Officer at Civetta Therapeutics LLC since 2021.
Prior to this, he was the Chief Scientific Officer at Black Diamond Therapeutics, Inc. from 2019 to 2021.
He also worked as the Vice President-Chemistry & Early Development at Syros Pharmaceuticals, Inc. from 2015 to 2017.
Before that, he was the VP & Head-Host Defense Discovery Performance Unit at GSK Plc from 2009 to 2015.
Dr. Roberts holds a doctorate degree from the University of California, Riverside and an undergraduate degree from Whitworth University.
Posizioni attive di Christopher D. Roberts
| Società | Posizione | Inizio |
|---|---|---|
Civetta Therapeutics LLC
 Civetta Therapeutics LLC Pharmaceuticals: MajorHealth Technology Civetta Therapeutics LLC develops therapeutics for cancers and other diseases. The company was founded by William Sellers and Eric Fischer and is headquartered in Cambridge, MA. | Amministratore Delegato | 02/09/2021 |
Precedenti posizioni note di Christopher D. Roberts
| Società | Posizione | Fine |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 11/08/2021 |
| SYROS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2017 |
| GSK PLC | Corporate Officer/Principal | 01/03/2015 |
Formazione di Christopher D. Roberts
| Whitworth University | Undergraduate Degree |
| University of California, Riverside | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| GSK PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Civetta Therapeutics LLC
Civetta Therapeutics LLC Pharmaceuticals: MajorHealth Technology Civetta Therapeutics LLC develops therapeutics for cancers and other diseases. The company was founded by William Sellers and Eric Fischer and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Christopher D. Roberts
